<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0812211438
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Concor Amlo
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BISOPROLOL FUMARATE,AMLODIPINE BESILATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5,5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        41.10
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="EGIS PHARMACEUTICALS PLC" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            EGIS PHARMACEUTICALS PLC
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Merck KFT
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07FB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Concor AMLO is indicated for the treatment of high blood pressure as substitution therapy in patients who are adequately controlled with the individual products given concurrently at the same doses level as in the combination, but as separate tablets.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Do not take Concor AMLO</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic&nbsp; to amlodipine, bisoprolol (active substances), dihydropyridine derivates or &nbsp;&nbsp;&nbsp;&nbsp; any of the other ingredients of this medicine (listed in section 6);</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have serious narrowing of the outflow tract of the left ventricle (e.g. high grade aortic stenosis);</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from acute heart failure, unstable heart failure after acute myocardial infarction or &nbsp;&nbsp; heart failure requiring intravenous drugs to increase strength of myocardial contraction;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from shock due to abnormal function of heart (in such cases blood pressure is extremly low and circulation is close to collapse);</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from heart disease characterized by very slow heart beat or irregular heart contraction (2<sup>nd</sup> or 3<sup>rd</sup> degree atrioventricular block, sinoatrial block, sick sinus syndrome);</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In case of extremly low blood pressure;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In case of slow heart rate;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In case of severe bronchial asthma;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In case of serious peripheral arterial disease;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In case of Raynaud syndrome, which is characterized by numbness, buzz and decoloration of fingers on hands and feet exposed to cold.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In case of untreated pheocromocytoma, which is a rare tumour of adrenal glands&rsquo; marrow;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In such metabolic conditions where pH of blood becomes acidic</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you think you suffer from any of the above mentioned diseases, ask your doctor whether you can take the preparation.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Warnings and precautions</strong><strong> </strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Talk to your doctor or pharmacist before taking Concor AMLO.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Concor AMLO can be administered with special care in the following conditions, therefore inform your doctor if any of the following conditions applies to you:</p><p dir="ltr"><strong><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>Elderly age;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Heart failure;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diabetes with highly variable blood sugar levels;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strict diet;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Concomittant antiallergic (desensitizing) treatment (e.g. in order to prevent allergic rhinitis);</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mild disorder of electronic regulatory system of heart rhythm (first degree AV-block);</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coronary perfusion disorder (Prinzmetal&rsquo;s angina)</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vascular disease of extremities characterized by decreased perfusion;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Psoriasis;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperthyreosis;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatic or renal disease;</p><p dir="ltr"><strong><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>In case of treated pheocromocytoma, which is a rare tumour of adrenal glands&rsquo; marrow;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bronchial asthma or other chronic obstructive lung disease;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are going to have an operation inform your anaesthetist, that you are taking Concor AMLO.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Your doctor may feel it necessary to take special measures (e.g. additional treatment), if any of the above conditions exists.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Children and adolescents</strong></p><p dir="ltr">Concor AMLO is not recommended for use in children below the age of 18 years due to the lack of data on safety and efficacy.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Other medicines and Concor AMLO</p><p dir="ltr">Therapeutic and side effects of this medicine may be biased by other medicines being concomitantly taken.</p><p dir="ltr">Interactions can arise, even if other medicine has been taken within just short time.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em><u>The coadministration of the following medicines with Concor AMLO is not recommended:</u></em></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Verapamil- and diltiazem type calcium channel blockers</em>: These drugs are used for the treatment of high blood pressure and chronic stable angina pectoris.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Centrally acting antihypertensives </em>(e.g.: clonidine, methyldopa, moxonodine, rilmenidine): Do not stop taking these drugs before consulting your doctor.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em><u>The following drugs may only be coadministered with Concor AMLO in certain circumstances with special caution under medical supervision: </u></em></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Certain heart rhythm regulator preparations</em> (quinidine, disopyramide, lidocaine, phenytoin, flecainide, propaphenon, amiodarone). These drugs are used for the treatment of irregular or abnormal heart rhythm.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Topically applied beta-blocker preparations</em> (e.g. eye-drops used to treat glaucoma).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Parasympathomimetics.</em> These drugs are used to potentiate function of smooth muscle in diseases of stomach, intestinum, bladder and in glaucoma.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Insulin and oral antidiabetics.</em></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Hypnotics,<strong> </strong></em>anaesthetic agents.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Heart glycosides (digitalis)</em>, drugs used to treat heart failure.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Non steroidal antiinflammatory drugs </em>(NSAIDs). These drugs may be given for the treatment of joint inflammation, pain or arthritis.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Sympathomimetics </em>(e.g. isoprenalin, dobutamine, norepinephrine, epinephrin). These drugs are used for the treatment of serious circulation disorders in case of emergence.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Any drugs lowering blood pressure due to therapeutic or adverse effect</em> (e.g. antihypertensive medicines, tricyclic antidepressants, barbiturates, phenothiazines).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Tacrolimus,</em> a medicine used to alter the way the immune system works.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Cyclosporine</em>, an immunosuppressant.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Dantrolene, </em>infusion for severe body temperature abnormalities.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Simvastatin</em>, a cholesterol lowering medicine.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em><u>Possible effects of a coadministration of the following medicines with Concor AMLO tablet need to be considered by your doctor:</u></em></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Mefloquine</em>, used to prevent or treat malaria.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Monoamino-oxidase (MAO) inhibitors</em> (except MAO-B inhibitors) used to treat depression.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Drugs affecting metabolism of amlodipine e.g.:</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ketoconazole, itraconazole (anti-fungal medicines)</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ritonavir, indinavir, nelfinavir (so called protease inhibitors used to treat HIV)</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rifampicin, erythromycin, clarithromycin (antibiotics)</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hypericum perforatum (St. John&rsquo;s Wort)</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Concor AMLO</em><em><u> </u></em>tablets with food, drink and alcohol</p><p dir="ltr">Alcohol may potentiate blood pressure lowering effect of the preparation.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Grapefruit juice and grapefruit should not be consumed by people who are taking <em>Concor AMLO</em>. This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active ingredient amlodipine, which can cause an unpredictable increase in the blood pressure lowering effect of <em>Concor AMLO</em>.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Pregnancy and breast-feeding</p><p dir="ltr"><em>Pregnancy</em></p><p dir="ltr">As no appropriate amount of clinical experience is available concerning pregnant women, it can be administered only after careful individual consideration of risk/benefit ratio by a doctor, therefore don&rsquo;t forget to inform your doctor if you may be pregnant or you plan to have a baby.</p><p dir="ltr">In case of its administration in pregnancy, careful monitoring of foetus&rsquo; and newborn&rsquo;s condition may be necessary.</p><p dir="ltr"><s>&nbsp;</s></p><p dir="ltr"><em>Breast-feeding</em></p><p dir="ltr">Amlodipine has been shown to pass into breast milk in small amounts. Concor AMLO is not recommended during breast-feeding.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Driving and using machines</p><p dir="ltr">Concor AMLO may impair driving or using machines by causing dizziness, headache, fatigue or nausea &ndash; especially when you start treatment or if your treatment is changed, and when you drink alcohol &ndash; therefore your doctor decides individually at what kind of dosage you can drive or use machines.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Important information about some of the ingredients of Concor AMLO</strong></p><p dir="ltr">This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ʻsodium-freeʼ.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p dir="ltr">The recommended dose is: one tablet of the strength prescribed for you.</p><p dir="ltr">Usually there is no need of dose adjustment in mild to moderate liver or kidney disease.</p><p dir="ltr">In serious liver or kidney disease doses may be modified.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Elderly</u></p><p dir="ltr">There is no need of dose adjustment in elderly patients, however, caution is advised when the dose is increased.</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>Administration</u></p><p dir="ltr">Concor AMLO should be taken in the morning, with or without food, with a little fluid without chewing it.</p><p dir="ltr">The score line is only there to help you break the tablet if you have difficulties swallowing it whole.</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you feel that the therapeutic effect of Concor AMLO is too strong or too weak, consult your doctor or pharmacist.</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you take more Concor AMLO than you should</p><p dir="ltr">If you take more &nbsp;Concor AMLO tablets than you should, consult a doctor immediately.</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you forget to take Concor AMLO</p><p dir="ltr">Try to make up missed dose as soon as possible. If it is already time to take next dose, do not take a double dose to make up for a forgotten dose, because you cannot compensate missed amount but you expose yourself to the risk of overdose.</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you stop taking Concor AMLO</p><p dir="ltr">Do not stop taking drug abruptly, or change recommended dose before consulting your doctor, as in such cases heart failure may temporarily worsen. Treatment must not been discontinued abruptly especially in patients with coronary disease. If cessation of treatment is necessary, dose must be reduced gradually.</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p dir="ltr">&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Visit your doctor immediately if you experience any of the following side effects after taking this medicine:</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe skin reactions including intense skin rash, hives, reddening of the skin over your whole body, severe itching, blistering, peeling and swelling of the skin, inflammation of mucous membranes (Stevens-Johnson syndrome, toxic epidermal necrolysis) or other allergic reactions</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><em>Very common: may affect more than 1 in 10 people</em></p><p dir="ltr">Oedema.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Common</em><em>: may affect up to 1 in 10 people</em></p><p dir="ltr">Headache, dizziness, somnolence (especially at the beginning of the treatment), palpitation, flush, abdominal pain, ankle swelling, fatigue, asthenia, feeling of coldness and numbness in the extremities, gastrointestinal complaints such as nausea, vomiting, altered bowel habits, diarrhoea, constipation, dyspepsia, visual disturbances (including diplopia), muscle cramps, dyspnoe.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Uncommon: may affect up to 1 in 100 people </em></p><p dir="ltr">Insomnia, mood changes (including anxiety), depression, temporary loss of consciousness (syncope), hypaesthesia, paraesthesia, abnormal sense of taste (dysgeusia), tremor, tinnitus, hypotension, rhinitis, cough, dry mouth, alopecia, small bleedings in the skin and mucosa (purpura), skin discolouration, increased sweating, itching, rash, exanthema, urticaria, arthralgia, myalgia, back pain, frequent micturition, micturition disorder, nycturia, impotence, breast enlargement in men, chest pain, pain, malaise, weight increase, weight decrease, sleep disorders, heart conduction disorders, deterioration of pre-existing heart failure, cardiac arrhythmia, slow heart rate (less than 50 beat per minute), low blood pressure, bronchospasm in patients with bronchial asthma or a history of obstructive pulmonary disease, muscle weakness.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Rare: may affect up to 1 in 1,000 people</em></p><p dir="ltr">Confusion, elevated level of triglyceride, nightmares, sense illusion, which is an abnormal sensation without detectable stimulus, similar to real sensation and seems real (hallucination), decreased tear secretion (it must be taken into consideration if you wear contact lenses), hearing impairments, allergic rhinitis, hepatitis, hypersensitivity reactions such as itching, flush, rash, elevated liver enzymes.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Very rare: may affect up to 1 in 10,000 people</em></p><p dir="ltr">Decrease of number or white blood cells and platelets, allergic reactions, elevated level of blood sugar, hypertonia, peripheral neuropathy, heart attack, patchy inflammation of small blood vessels (vasculitis), gastritis, gingival hyperplasia, pancreatitis, jaundice, acute swelling of skin or mucosa involving most frequently eyelids, lips, joints, genitals, glottis, pharynx and tongue (angio-oedema), serious inflammation of skin or mucosa with red vesicles (erythema multiforme), widespread erythema and scaling of the skin (exfoliative dermatitis), serious blistering lesions of the skin and mucous membranes of the mouth, genital and anal regions, with fever, sore throat and fatigue (Stevens-Johnson syndrome), sensitivity to the sunlight, conjunctivitis, drugs with similar mechanism of action than bisoprolol (active ingredient of the preparation) may evoke or worsen psoriasis (chronic skin disease with itchy scaly red patches) or may cause psoriasis-like skin disorder, disorders combining involuntary movements, muscle rigidity and contractions, tremor (extrapyramidal syndrome).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Keep this medicine out of the sight and reach of children.</p><p dir="ltr">&nbsp;</p><p dir="ltr">This medicinal product does not require any special temperature storage conditions. Store in the original container in order to protect from light.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Do not use this medicine after the expiry date which is stated on the carton (year/month). The expiry date refers to the last day of that month.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Do not use this medicine tablet if you notice the visible signs (discoloration) of deterioration.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">What Concor AMLO contains</p><p dir="ltr">&nbsp;</p><p dir="ltr">- The active substances are:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Concor AMLO 5 mg/5 mg tablets</u></p><p dir="ltr">5 mg bisoprolol fumarate and 5 mg amlodipine (as besilate)</p><p dir="ltr"><u>Concor AMLO 5 mg/10 mg tablets</u></p><p dir="ltr">5 mg bisoprolol fumarate and 10 mg amlodipine (as besilate)</p><p dir="ltr">&nbsp;</p><p dir="ltr">- The other ingredients are:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Silica, colloidal anhydrous, magnesium stearate, sodium starch glycolate (type A), microcrystalline cellulose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Concor AMLO 5 mg/5 mg tablets:	White or almost white, odourless, oblong, slightly convex tablets with a length of 9.5 mm and a width of 4.5 mm with score line on one side and with embossed MS on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.

Concor AMLO 5 mg /10 mg tablets:	White or almost white, odourless, round, flat, bevel edged tablets of 10 mm with score line on one side and with embossed MS on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.



Concor AMLO comes in packs of
28, 30, 56, or 90 tablets in OPA/Al/PVC//Al blister and carton box.
Not all pack sizes may be marketed.






            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Marketing Authorisation Holder</p><p dir="ltr">&nbsp;</p><p dir="ltr">Merck KFT</p><p dir="ltr">Oktober huzonharmadika utca 6-10</p><p dir="ltr">H-1117, Budapest</p><p dir="ltr">Hungary</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">Manufacturers</p><p dir="ltr">&nbsp;</p><p dir="ltr">EGIS Pharmaceuticals PLC</p><p dir="ltr">H-1165 Budapest, B&ouml;k&eacute;nyf&ouml;ldi &uacute;t 118-120.</p><p dir="ltr">Hungary</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 01 March 2021 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">كونكور أملو يُستعمَل كعلاج بديل لعلاج ضغط الدم المرتفع لدى المرضى الذين يخضع مرضهم للتحكّم بالشكل المناسب بواسطة المنتجات الفردية التي تُعطى بشكل متزامن وبنفس مستوى الجرعات التي تحتوي عليها التوليفة، وإنما في شكل أقراص منفصلة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تتناول كونكور أملو</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني حساسيةً تجاه أملوديبين أو بيزوبرولول (المادتين الفعالتين) أو مشتقات ثنائي هيدرو البيريدين أو أيّ من مكونات هذا الدواء الأخرى (والواردة في القسم 6).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني تضيقًا خطِرًا في مخرج البُطَين الأيسر (على سبيل المثال، تضيّق الأبهر عالي الدرجة).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني فشلاً قلبيًا حادًا أو فشلاً قلبيًا غير مستقرّ بعد احتشاء حادّ في عضلة القلب أو فشلاً قلبيًا يستدعي عقاقير في الوريد لزيادة قوة انقباض عضلة القلب.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني صدمةً نتيجةً لوظيفة القلب غير الطبيعية (في هذه الحالات، يكون ضغط الدم منخفضاً للغاية والدورة الدموية على وشك الهبوط).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني مرضًا قلبيًا يتّسم ببطءٍ شديدٍ في نبض القلب أو انقباض القلب غير المنتظم (انسداد أُذَيني بُطَيني من الدرجة الثانية أو الثالثة، انسداد جَيبي أذَيني، متلازمة العقدة الجيبية المريضة).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالات انخفاض ضغط الدم الشديد.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالات معدّل ضربات القلب البطيء.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالات الربو القَصَبي الشديد.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالات مرض الشريان الطرفي الخطِر.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالات متلازمة رينو، والتي تتّسم بخدر أصابع اليدين والرجلين عند تعرّضها للبرد، ووخزها، وتغيّر لونها.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالات ورم القواتم غير المُعالَج، وهو ورم نادر يصيب نخاع الغدد الكظرية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في الحالات المَرَضية الأيضية حيث يتحوّل أسّ الدم الهيدروجيني إلى حمضي</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنت تظن أنك تعاني أيّاً من الحالات المذكورة أعلاه، فاسأل طبيبك إذا كان يجب عليك تناول هذا المستحضر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات </strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">تحدّث إلى طبيبك أو الصيدلي قبل تناول كونكور أملو.</p><p dir="RTL">&nbsp;</p><p dir="RTL">بالإمكان تناول كونكور أملو مع توخي العناية الخاصة في الحالات المَرَضية التالية؛ ومع هذا، أعلِم طبيبك إذا كان أيٌّ من الحالات التالية ينطبق عليك:</p><p dir="RTL"><strong><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>التقدّم في السن.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل القلب.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض السكري المصحوب بمستويات سكر في الدم تتغيّر بشكل كبير.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النظام الغذائي الصارم.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العلاج المصاحب بمضادات الحساسية (مُزيلات التحسُّس) (على سبيل المثال، للوقاية من التهاب غشاء الأنف المخاطي التحسُّسي).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب نظام تنظيم إيقاع القلب الإلكتروني الخفيف (الانسداد الأُذَيني البُطَيني من الدرجة الأولى).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب تروية الوعاء التاجي (ذبحة برِنزميتال).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض الأطراف الوعائي الذي يتّسم بتدنّي التروية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصَدَفية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط نشاط الغدة الدرقية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض كبدي أو كلوي.</p><p dir="RTL"><strong><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>في حالات ورم القواتم المُعالَج، وهو ورم نادر يصيب نخاع الغدد الكظرية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الربو القَصَبي أو غيره من الأمراض السادّة للرئتين.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت سوف تخضع لعملية جراحية، فأعلِم طبيب التخدير بأنك تتناول كونكور أملو.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يرى طبيبك أنه من الضروري اتخاذ تدابير خاصة (على سبيل المثال، علاج إضافي)، في حال وجود أيٍّ من الحالات المَرَضية المذكورة أعلاه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال والمراهقون</strong></p><p dir="RTL">يُوصى بعدم استعمال كونكور أملو للأطفال ما دون 18&nbsp;عامًا من العمر بسبب نقص البيانات عن أمانه وفعاليته.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية الأخرى وكونكور أملو</p><p dir="RTL">قد تؤثر الأدوية الأخرى التي تتناولها بمصاحبة هذا الدواء في كلٍ من تأثيره العلاجي وآثاره الجانبية.</p><p dir="RTL">قد تحدث التفاعلات، حتى في حال تناول الدواء الآخر لمدة قصيرة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أدوية أخرى أو تناولتها مؤخراً أو إذا كان من المحتمل أن تتناولها في المستقبل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em><u>يُوصى بعدم تناول الأدوية التالية بالتزامن مع كونكور أملو:</u></em></p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>حاصرات قنوات الكالسيوم من نوع فيراباميل أو ديلتيازيم</em>: تُستعمَل هذه الأدوية لعلاج ضغط الدم المرتفع والذبحة الصدرية المستقرّة المزمنة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>مضادات ارتفاع ضغط الدم ذات التأثير المركزي </em>(على سبيل المثال، كلونيدين، وميثيلدوبا، وموكسونودين، وريلمينيدين): لا تتوقف عن تناول هذه الأدوية قبل استشارة طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em><u>لا يجوز تناول العقاقير التالية بالتزامن مع كونكور أملو سوى في ظروف معينة، وذلك بتوخي الحذر الخاص وبإشراف الطبيب:</u></em></p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>بعض مستحضرات تنظيم إيقاع ضربات القلب </em>(كينيدين، ديزوبيراميد، ليدوكاين، فينيتوين، فليكاينيد، بروبافينون، أميودارون). تُستعمَل هذه الأدوية لعلاج إيقاع ضربات القلب غير المنتظم أو غير الطبيعي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>مستحضرات حاصرات مستقبلات بيتا التي تُستعمَل موضعياً </em>(على سبيل المثال، قطرات العينين المُستعمَلة لعلاج الزرق).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>مُنبِّهات العَصَب نظير الودي.</em> تُستعمَل هذه الأدوية لتعزيز وظيفة العضلة الملساء في أمراض المعدة، والأمعاء، والمثانة، وفي حالات الزرق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>الأنسولين ومضادات السكري الفموية.</em></p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>المُنوّمات</em>، وعوامل التخدير.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>غليكوزيدات القلب (الديجيتال)</em>، وهي أدوية تُستعمَل لعلاج فشل القلب.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>العقاقير المضادة للالتهاب غير الستيرويدية </em>(Non Steroidal Antiinflammatory Drugs, NSAIDs&rlm;). يجوز إعطاء هذه الأدوية لعلاج التهابات المفاصل أو آلامها أو التهاب المفاصل الروماتويدي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>محاكيات الودي </em>(على سبيل المثال، إيزوبرينالين، ودوبوتامين، ونوريبينيفرين، وإيبينيفرين). تُستعمَل هذه الأدوية لعلاج اضطرابات الدورة الدموية الخطِرة في حالات الطوارئ.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>أيّ أدوية تخفّض ضغط الدم نتيجةً لتأثيرها العلاجي أو أثرها السلبي </em>(على سبيل المثال، الأدوية المضادة لفرط التحسُّس، ومضادات الاكتئاب ثلاثية الحلقات، والباربيتورات، والفينوثيازين).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>تاكروليموس، </em>وهو دواء يُستعمَل لتعديل طريقة عمل جهاز المناعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>سيكلوسبورين</em>، وهو كابت للمناعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>دانترولين، </em>وهو نقوع لحالات حرارة الجسم غير الطبيعية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>سيمفاستاتين</em>، وهو دواء يخفّض معدّلات الكولسترول.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em><u>يجب على طبيبك أن يفكّر في الآثار المحتملة الناتجة عن تناول الأدوية التالية بالتزامن مع أقراص كونكور أملو:</u></em></p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>ميفلوكين</em>، يُستعمَل للوقاية من الملاريا أو علاجها.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>ناهضات أكسيداز أحادي الأمين (</em><em>Monoamino-oxidase, MAO</em><em>&rlm;) </em>(باستثناء ناهضات أكسيداز أحادي الأمين-ب) المُستعمَلة لعلاج الاكتئاب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">العقاقير التي تؤثر في أيض أملوديبين، على سبيل المثال:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كيتوكونازول، وإتيراكونازول (أدوية مضادة للفطريات)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ريتونافير، وإندينافير، ونِلفينافير (المدعوّة ناهضات البروتياز، والمُستعمَلة لعلاج فيروس نقص المناعة البشرية)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ريفامبيسين، وإيريثروميسين، وكلاريثروميسين (مضادات حيوية)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العَرَن المثقوب (نبتة سانت جون)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>أقراص كونكور أملو</em> مع الطعام والشراب والكحول</p><p dir="RTL">قد يعزز الكحول تأثير تخفيض ضغط الدم في المستحضر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب على الأشخاص الذين يتناولون <em>كونكور أملو</em> عدم استهلاك الغريبفروت وعصير الغريبفروت. ذلك أن الغريبفروت وعصير الغريبفروت قد يؤديان إلى زيادة في مستويات المادة الفاعلة أملوديبين في الدم، الأمر الذي قد يسبّب ارتفاعًا غير متوقع في ضغط الدم، يخفض من تأثير <em>كونكور أملو</em>.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الحمل والإرضاع الطبيعي</p><p dir="RTL"><em>الحمل</em></p><p dir="RTL"><strong>بسبب عدم توفّر عدد كافٍ من التجارب السريرية المتعلّقة بالنساء الحوامل، لا يجوز تناوله سوى بعد أن يفكّر الطبيب وبحذِر في نسبة المخاطر مقابل الفوائد بحسب حالتك الصحية الشخصية؛ بالتالي، لا تنسَي إعلام طبيبك إذا كنت قد تكونين حاملاً أو تنوين إنجاب طفل.</strong></p><p dir="RTL">في حال تناوله في خلال الحمل، قد يكون من الضروري مراقبة حالة الجنين والمولود الحديث المَرَضية عن كثب.</p><p dir="RTL"><s>&nbsp;</s></p><p dir="RTL"><em>الرضاعة الطبيعية</em></p><p dir="RTL"><em>أثبت أملوديبين عبوره بكميات صغيرة إلى حليب الأم. لا يُوصى بتناول كونكور أملو في خلال الإرضاع الطبيعي. </em></p><p dir="RTL">&nbsp;</p><p dir="RTL">القيادة واستعمال الآلات</p><p dir="RTL"><strong>قد يعيق كونكور أملو</strong><strong> القيادة أو استعمال الآلات من خلال التسبّب بالدُوار أو الصداع أو الإرهاق أو الغثيان - خصوصًا عند بداية العلاج أو عند تغيير علاجك، وعندما تشرب الكحول - وبالتالي، سوف يقرّر طبيبك مقدار الجرعة التي تسمح لك بالقيادة أو استعمال الآلات بحسب حالتك الصحية الشخصية.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات مهمة حول بعض مكونات كونكور أملو</strong></p><p dir="RTL">يحتوي هذا الدواء على أقل من 1 مللي مول من الصوديوم (23 ملغ) لكل قرص، وهو ما يعني أساسًا أنه &rsquo;خالٍ من الصوديوم&lsquo;.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك دائما تناول هذا الدواءً بحسب توجيهات الطبيب تمامًا. واستشر طبيبك أو الصيدلاني إذا كنت غير متأكد من طريقة الاستخدام.</p><p dir="RTL">الجرعة المُوصى بها هي: قرص واحد من العيار الموصوف لك.</p><p dir="RTL">لا يكون هناك حاجة عادةً لتعديل الجرعة في حالات مرض الكبد أو الكلى الخفيف إلى المعتدل.</p><p dir="RTL">ويجوز تعديل الجرعات في حالات مرض الكبد أو الكلى الخطِرة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>كبار السن</u></p><p dir="RTL">لا يكون هناك حاجة إلى تعديل الجرعة لدى المرضى من كبار السن؛ وإنما يجب التوصية بتوخّي الحذر عند زيادة الجرعة.</p><p dir="RTL"><u>&nbsp;</u></p><p dir="RTL"><u>تناول الدواء</u></p><p dir="RTL">يجب تناول كونكور أملو في الصباح، مع الطعام أو بدونه، وشرب القليل من السائل معه، وعدم مضغه.</p><p dir="RTL">يتوفّر خطّ الفصل فقط لمساعدتك على قسمة القرص إذا وجدت صعوبة في بلعه كاملاً.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا شعرت بأن تأثير كونكور أملو العلاجي قوي للغاية أو ضعيف للغاية، فاستشر طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا تناولت كمية أكبر ممّا يجب من كونكور أملو</p><p dir="RTL">إذا تناولت عددًا أكبر ممّا يجب من أقراص كونكور أملو، فاستشر الطبيب على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا نسيت تناول كونكور أملو</p><p dir="RTL">حاول التعويض عن الجرعة الفائتة في أقرب وقت ممكن. إذا كان الوقت قد حان لتناول الجرعة التالية، فلا تتناول جرعة مضاعفة للتعويض عن الجرعة الفائتة، لأن ذلك لا يسمح لك بالتعويض عن الكمية الفائتة بل يعرّضك لخطر جرعة زائدة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا توقفت عن تناول كونكور أملو</p><p dir="RTL">لا تتوقف عن تناول العقار بشكل مفاجئ أو تغيّر الجرعة الموصى بها قبل استشارة طبيبك، إذ إن فشل القلب قد يسوء مؤقتاً في مثل هذه الحالات. يجب عدم إيقاف العلاج بشكل مفاجئ وخصوصاً لدى المرضى المصابين بمرض الشريان التاجي. إذا كان إيقاف العلاج ضرورياً، فيجب عندها تخفيض الجرعة تدريجياً.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كانت لديك أيّ أسئلة إضافية بخصوص استعمال هذا الدواء، فاستشر طبيبك أو الصيدلاني.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية، من الممكن أن يسبب هذا الدواء آثارًا جانبية على الرغم من أنها لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">اقصد طبيبك على الفور إذا عانيت أيّاً من الآثار الجانبية التالية بعد تناول هذا الدواء:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود فعل جلدية شديدة بما فيها الطفح الجلدي الشديد، والشَرَى، واحمرار الجلد على امتداد كامل جسمك، والحكة الشديدة، والبثور، وتقشّر الجلد وتورّمه، والتهاب الأغشية المخاطية (متلازمة ستيفنز جونسون، تقشر الأنسجة المتموتة البشروية التسممي) أو ردود فعل تحسسية أخرى</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>الشائعة جداً: قد تصيب أكثر من 1&nbsp;من كل 10&nbsp;أشخاص</em></p><p dir="RTL">الوذمة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>الشائعة: قد تصيب 1&nbsp;من كل 10&nbsp;أشخاص</em></p><p dir="RTL">الصداع، والدُوار، والنعاس (خصوصاً عند بداية العلاج)، والخفقان، والبَيغ، وألم البطن، وتورّم الكاحلين، والإرهاق، والوَهَن، والشعور بالبرودة والخدر في الأطراف، ومشكلات الجهاز الهضمي مثل الغثيان، والقيء، وتغيّر عادات التغوّط، والإسهال، والإمساك، وعسر الهضم، واضطرابات النظر (بما فيها ازدواج الرؤية)، والتشنجات العضلية، وضيق التنفس.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>غير الشائعة: قد تصيب 1&nbsp;من كل 100&nbsp;شخص</em></p><p dir="RTL">الأرق، وتقلّبات المزاج (بما فيها الهلع)، والاكتئاب، وفقدان الوعي المؤقت (الغَشي)، ونقص الحسّ، والمَذَل، وحاسة الذوق غير الطبيعية (خلل الذوق)، والرعشة، وطنين الأذن، وانخفاض ضغط الدم، والتهاب غشاء الأنف المخاطي، والسُعال، وجفاف الفم، والثعلبة، وحالات النزيف الصغيرة في البشرة والأغشية المخاطية (الفُرفُرية)، وتغيّر لون البشرة، وزيادة التعرّق، والحكة، والطفح الجلدي، والطفح الظاهر، والشَرَى، والألم المفصلي، والألم العضلي، وألم الظهر، والتبوّل المتكرر، واضطراب التبوّل، والتبوّل الليلي، والعجز الجنسي، وتضخّم الثديين لدى الرجال، وألم الصدر، والألم، والوعكة، وزيادة الوزن، ونقص الوزن، واضطرابات النوم، واضطرابات نظام التوصيل الكهربائي للقلب، وتدهور حالة فشل القلب الموجودة سابقاً، واختلال نظم القلب، ومعدل ضربات القلب البطيء (أقل من 50&nbsp;ضربة في الدقيقة)، وضغط الدم المنخفض، والتشنجات القَصَبية لدى المرضى المصابين بالربو القَصَبي أو الذين لديهم تاريخ من الإصابة بمرض رئوي سادّ، وضعف العضلات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>النادرة: قد تصيب حتى 1&nbsp;من بين كل 1,000&nbsp;شخص</em></p><p dir="RTL">الارتباك، وارتفاع مستويات ثلاثي الغليسريدات، والكوابيس، ووهم الحواس، وهو عبارة عن إحساس غير طبيعي بدون وجود حافز ملموس، مشابه لإحساس حقيقي ويبدو حقيقياً (هلوسة)، وتدنّي إفراز الدمع (يجب أخذه في الاعتبار إذا كنت ترتدي عدسات لاصقة)، وضعف السمع، والتهاب غشاء الأنف المخاطي التحسّسي، والتهاب الكبد، وردود فعل فرط الحساسية مثل الحكة، والبَيغ، والطفح الجلدي، وارتفاع نسبة إنزيمات الكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>النادرة جداً: قد تصيب حتى 1&nbsp;من بين كل 10,000&nbsp;شخص</em></p><p dir="RTL">تدنّي عدد خلايا الدم البيضاء وصفائح الدم، وردود الفعل التحسّسية، وارتفاع مستوى السكر في الدم، وفرط التوتر، واعتلال الأعصاب الطرفي، والنوبات القلبية، والتهاب الأوعية الدموية الصغيرة الرُقَعي (الالتهاب الوعائي)، والتهاب المعدة، وفرط تنسّج اللثة، والتهاب البنكرياس، واليرقان، وتورّم الجلد أو الأغشية المخاطية الحادّ، والذي يشمل في الغالب الجفنين والشفتين والمفاصل والأعضاء التناسلية والمزمار والبلعوم واللسان (الوذمة الوعائية)، والتهاب الجلد أو الأغشية المخاطية الخطِر المصحوب بحُوَيصلات حمراء (الحُمامى متعددة الأشكال)، والحُمامى واسعة الانتشار وتقشّر الجلد (التهاب الجلد التقشّري)، وإصابات البثور الخطِرة في الجلد، وأغشية الفم المخاطية، والمناطق التناسلية والمناطق المحيطة بفتحة الشرج، والمصحوبة بالحُمّى، وألم الحلق، والإرهاق (متلازمة ستيفنز جونسون)، والحساسية لضوء الشمس، والاختلاجات، ويمكن للعقاقير ذات آلية العمل المماثلة لتك الخاصة ببيسوبرولول (المادة الفعالة في المستحضر) أن تثير صدفية (مرض جلدي مزمن مع بقع حمراء متقشرة حاكة) أو تتسبب في تفاقمها أو أن تتسبب في اضطرابات جلدية شبيهة بالصدفية، أو اضطرابات تجمع بين الحركات اللاإرادية والصمل العضلي والتقلصات والرعشة (متلازمة خارج السبيل الهرمي).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيدًا عن متناول الأطفال وأنظارهم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>هذا المنتج الطبي لا يتطلب أي ظروف درجات حرارة تخزين خاصة. احفظ الدواء في عبوته الأصلية لحمايته من الضوء.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستعمل هذا الدواء بعد تاريخ انتهاء صلاحيته المذكور على ملصق العلبة (السنة/الشهر). يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستعمل هذه الأقراص الدوائية إذا لاحظت أيّ علامات (تغيّر في اللون) تشير إلى تلفها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا ترمِ أيّ أدوية في مياه الصرف أو النفايات المنزلية. اسأل الصيدلاني عن طريقة التخلص من الأدوية التي ما عدت تستعملها. تساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">محتويات كونكور أملو</p><p dir="RTL">&nbsp;</p><p dir="RTL">- المادتان الفاعلتان هما:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>أقراص كونكور أملو 5&nbsp;ملغ/5&nbsp;ملغ</u></p><p dir="RTL">بيزوبرولول فومارات 5&nbsp;ملغ وأملوديبين 5&nbsp;ملغ (في صورة بيزيلات)</p><p dir="RTL"><u>أقراص كونكور أملو</u><u> 5&nbsp;ملغ/10&nbsp;ملغ</u></p><p dir="RTL">بيزوبرولول فومارات 5&nbsp;ملغ وأملوديبين 10&nbsp;ملغ (في صورة بيزيلات)</p><p dir="RTL">&nbsp;</p><p dir="RTL">- المكونات الأخرى هي:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيليكا، غَرَواني لامائي، ستيارات المغنيزيوم، غليكولات نشاء الصوديوم (النوع أ)، سيليلوز بلّوري دقيق.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شكل كونكور أملو ومحتويات العلبة</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><u>أقراص كونكور أملو</u><u> 5&nbsp;ملغ/5&nbsp;ملغ:</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص بيضاء أو شبه بيضاء، عديمة الرائحة، مستطيلة، قليلة التحدّب، بطول 9,5&nbsp;ملم وعرض 4,5&nbsp;ملم، مع خطّ فاصل على أحد جانبيها، وحرفَي MS&rlm; محفوران على الجانب الآخر. الغرض من الخط الفاصل فقط تسهيل قسمتها لسهولة ابتلاعها وليس لقسمتها إلى جرعتين متساويتين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>أقراص كونكور أملو</u><u> 5&nbsp;ملغ/10&nbsp;ملغ:</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص بيضاء أو شبه بيضاء، عديمة الرائحة، مستديرة، مسطّحة، أطرافها مشطوبة، بطول 10&nbsp;ملم، مع خطّ فاصل على أحد جانبيها، وحرفَي MS&rlm; محفوران على الجانب الآخر. الغرض من الخط الفاصل فقط تسهيل قسمتها لسهولة ابتلاعها وليس لقسمتها إلى جرعتين متساويتين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">يأتي كونكور أملو في عبوات من</p><p dir="RTL">28 أو 30 أو 56 أو 90 قرصًا في شريط OPA/Al/PVC/Al وعلبة كرتون.</p><p dir="RTL">قد لا تُسوَّق جميع أحجام العلب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشركة المسوقه</p><p dir="RTL">&nbsp;</p><p dir="RTL">ميرك KFT</p><p dir="RTL">أكتوبر huzonharmadika utca 6-10</p><p dir="RTL">H-1117 ، بودابست</p><p dir="RTL">هنغاريا</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشركه المصنعه </strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">EGIS Pharmaceuticals PLC</p><p dir="RTL">H-1165 Budapest، B&eacute;k&eacute;nyf&ouml;ldi &uacute;t 118-120.</p><p dir="RTL">هنغاريا</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم مراجعة النشره في 01 مارس 2021 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Concor AMLO 5 mg/5 mg tablets
Concor AMLO 5 mg/10 mg tablets

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Concor AMLO 5 mg/5 mg tablets: 5 mg bisoprolol fumarate, 5 mg amlodipine (as besilate) per tablet. 
Concor AMLO 5 mg/10 mg tablets: 5 mg bisoprolol fumarate, 10 mg amlodipine (as besilate) per tablet.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablet.

Concor AMLO 5 mg/5 mg tablets:	White or almost white, odourless, oblong, slightly convex tablets with a length of 9.5 mm and a width of 4.5 mm with score line on one side and with embossed MS on the other side.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.

Concor AMLO 5 mg/10 mg tablets:	White or almost white, odourless, round, flat, bevel edged tablets of 10 mm with score line on one side and embossed MS on the other side.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.



            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Concor AMLO is indicated for the treatment of hypertension as substitution therapy in patients adequately controlled with the individual products given concurrently at the same doses level as in the combination, but as separate tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Concor AMLO is indicated in patients whose blood pressure is adequately controlled with separately administered monocomponent preparations of the same doses as the recommended fixed dose combination.</p><p dir="ltr">Posology<br />Recommended daily dose is one tablet of the given strength.&nbsp;<br />Treatment must not be abruptly discontinued, as it may lead to temporary deterioration of clinical condition. Treatment must not be abruptly discontinued especially in case of patients suffering from ischaemic heart disease. Gradual decrease of the dose is recommended.</p><p dir="ltr">Patients with hepatic impairment<br />In case of hepatic impairment elimination of amlodipine may be elongated. Dosage recommendations concerning amlodipine have not been established in patients with mild to moderate hepatic impairment. The pharmacokinetics of amlodipine have not been studied in severe hepatic impairment. The drug should therefore be administered with special caution in patients with hepatic impairment (see section 4.4).&nbsp;<br />In case of severe hepatic impairment the daily dose of bisoprolol must not exceed 10 mg.</p><p dir="ltr">Patients with renal impairment<br />No dosage adjustment is required for patients with mild to moderate renal impairment.&nbsp;<br />Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment. Amlodipine is not dialyzable (see section 4.4).<br />In case of severe renal impairment (creatinin clearance &lt; 20 ml/min) the daily dose of bisoprolol must not exceed 10 mg.</p><p dir="ltr">Elderly patients<br />The usual doses can be administered to elderly people; however, caution is advised when the dose is increased (see section 5.2).</p><p dir="ltr">Paediatric population<br />The safety and efficacy of Concor AMLO in children and adolescents below the age of 18 years have not been established. No data are available.</p><p dir="ltr">Method of administration<br />Concor AMLO should be taken in the morning with or without food, without chewing it.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
In connection with amlodipine:
-	severe hypotension 
-	shock (including cardiogenic shock)
-	obstruction of the outflow tract of the left ventricle (e.g. high-grade aortic stenosis)
-	haemodynamically unstable heart failure after acute myocardial infarction

In connection with bisoprolol:
-	Acute heart failure or during episodes of heart failure decompensation requiring i.v. inotropic therapy
-	Cardiogenic shock
-	Second- or third-degree AV block (without a pacemaker) 
-	Sick sinus syndrome
-	Sinoatrial block
-	Symptomatic bradycardia 
-	Symptomatic hypotension 
-	Severe bronchial asthma 
-	Severe forms of peripheral arterial occlusive disease and severe forms of Raynaud's syndrome
-	Untreated pheochromocytoma (see section 4.4) 
-	Metabolic acidosis

In connection with Concor AMLO:
-	Hypersensitivity to amlodipine, dihydropyridine derivates, bisoprolol and/or to any of the excipients listed in section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>In connection with amlodipine:</u></p><p dir="ltr">The safety and efficacy of amlodipine in hypertensive crisis has not been established.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Patients with cardiac failure</em></p><p dir="ltr">Patients with heart failure should be treated with caution. In a long-term, placebo-controlled study in patients with severe heart failure (NYHA class III and IV) the reported incidence of pulmonary oedema was higher in the amlodipine treated group than in the placebo group (see section 5.1). Calcium channel blockers, including amlodipine, should be used with caution in patients with congestive heart failure, as they may increase the risk of future cardiovascular events and mortality.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Use in patients with impaired hepatic function</em></p><p dir="ltr">The half-life of amlodipine is prolonged and AUC values are higher in patients with impaired liver function; dosage recommendations have not been established. Amlodipine should therefore be administered with caution in these patients. Careful monitoring may be required in patients with severe hepatic impairment.</p><p dir="ltr"><em>Use in elderly patients</em></p><p dir="ltr">In the elderly increase of the dosage should take place with care (see section 5.2).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Use in renal failure </em></p><p dir="ltr">Amlodipine may be used in such patients at normal doses. Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment. Amlodipine is not dialyzable.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>In connection with bisoprolol:</u></p><p dir="ltr">Especially in case of patients suffering from ischaemic heart disease the cessation of therapy with bisoprolol must not be done abruptly unless clearly indicated, as it may lead to temporary deterioration of heart disease (see section 4.2).</p><p dir="ltr">Bisoprolol should be administered with special caution in patients with hypertension or angina associated with heart failure.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol must be used with caution in:</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diabetes mellitus with large fluctuations in blood glucose values; symptoms of hypoglycaemia (e.g. tachycardia, palpitations or sweating) can be masked.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strict fasting/diet.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Concomitant desensitisation therapy. As with other beta-blockers, bisoprolol may increase both the sensitivity towards allergens and the severity of anaphylactic reactions. Adrenaline treatment may not always give the expected therapeutic effect.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; First degree AV block.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prinzmetal&#39;s angina; Cases of coronary vasospasm have been observed. Despite its high beta1-selectivity, angina attacks cannot be completely excluded when bisoprolol is administered to patients with Prinzmetal&#39;s angina.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Peripheral arterial occlusive disease (intensification of complaints might happen especially during the start of therapy),</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patients with psoriasis or with a history of psoriasis should only be given beta-blockers (e.g. bisoprolol) after carefully balancing the benefits against the risks.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Under treatment with bisoprolol the symptoms of hyperthyreosis may be masked.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In patients with pheochromocytoma bisoprolol must not be administered until after alpha-receptor blockade.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In patients undergoing general anaesthesia beta-blockade reduces the incidence of arrhythmias and myocardial ischemia during induction of anaesthesia and intubation, and the post-operative period. It is currently recommended that maintenance beta-blockade be continued perioperatively. The anaesthetist must be aware of beta-blockade because of the potential for interactions with other drugs, resulting in bradyarrhythmia&#39;s, attenuation of the reflex tachycardia and the decreased reflex ability to compensate for blood loss.</p><p dir="ltr">If it is thought necessary to withdraw beta-blocker therapy before surgery, this should be done gradually and completed about 48 hours before anaesthesia.</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Although cardio selective (beta1) beta-blockers may have less effect on lung function than non-selective beta-blockers, as with all beta-blockers, these should be avoided in patients with obstructive airway diseases, unless there are compelling clinical reasons for their use. Where such reasons exist, Concor AMLO may be used with caution. In bronchial asthma or other chronic obstructive lung diseases, which may cause symptoms, bronchodilation therapy should be given concomitantly. Occasionally an increase of the airway resistance may occur in patients with asthma, therefore the dose of &beta;2-stimulants may have to be increased.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>In connection with excipients:</u></p><p dir="ltr">This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ʻsodium-freeʼ.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>In connection with amlodipine:</u></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Effects of other medicinal products on amlodipine</em></p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>CYP3A4 inhibitors:</em> Concomitant use of amlodipine with strong or moderate inhibitors of CYP3A4 (e.g. protease inhibitors like indinavir, saquinavir and ritonavir, azole antifungals such as fluconazole and itraconazole, macrolides like erythromycin or clarithromycin, verapamil or diltiazem) may give rise to significant increase in amlodipine exposure resulting in an increased risk of hypotension. The clinical translation of these PK variations may be more pronounced in the elderly. Clinical monitoring and dose adjustment may thus be required.</p><p dir="ltr"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><em>CYP3A4 inducers:</em> Upon co-administration of known inducers of the CYP3A4, the plasma concentration of amlodipine may vary. Therefore, blood pressure should be monitored and dose regulation considered both during and after concomitant medication particularly with strong CYP3A4 inducers (e.g. rifampicin, hypericum perforatum).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Administration of amlodipine with grapefruit or grapefruit juice is not recommended as bioavailability may be increased in some patients resulting in increased blood pressure lowering effects.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Dantrolene (infusion)</em></p><p dir="ltr">In animals, lethal ventricular fibrillation and cardiovascular collapse are observed in association with hyperkalemia after administration of verapamil and intravenous dantrolene. Due to risk of hyperkalemia, it is recommended that the co-administration of calcium channel blockers such as amlodipine be avoided in patients susceptible to malignant hyperthermia and in the management of malignant hyperthermia.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Effects of amlodipine on other medicinal products</em></p><p dir="ltr">The blood pressure lowering effects of amlodipine adds to the blood pressure-lowering effects of other medicinal products with antihypertensive properties.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Tacrolimus</em></p><p dir="ltr">There is a risk of increased tacrolimus blood levels when co-administered with amlodipine, but the pharmacokinetic mechanism of this interaction is not fully understood. In order to avoid toxicity of tacrolimus, administration of amlodipine in a patient treated with tacrolimus requires monitoring of tacrolimus blood levels and dose adjustment of tacrolimus when appropriate.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Cyclosporine</em></p><p dir="ltr">No drug interaction studies have been conducted with cyclosporine and amlodipine in healthy volunteers or other populations with the exception of renal transplant patients, where variable trough concentration increases (average 0% - 40%) of cyclosporine were observed. Consideration should be given for monitoring cyclosporine levels in renal transplant patients on amlodipine, and cyclosporine dose reductions should be made as necessary.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Simvastatin</em></p><p dir="ltr">Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin alone. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In clinical interaction studies, amlodipine did not affect the pharmacokinetics of atorvastatin, digoxin, or warfarin.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>In connection with bisoprolol:</u></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Combinations not recommended:</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Calcium antagonists of verapamil type</em> and to a lesser extent of diltiazem type: Negative influence on contractility, atrio-ventricular conduction and blood pressure. Intravenous administration of verapamil in patients on &beta;-blocker treatment may lead to profound hypotension and atrioventricular block.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Centrally acting antihypertensive drugs</em> such as clonidine, methyldopa, moxonodine, rilmenidine: Concomitant use of centrally acting antihypertensive drugs may lead to reduction of heart rate and cardiac output and vasodilation. Abrupt withdrawal of the drug may increase the risk of &ldquo;rebound hypertension&rdquo;.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Combinations to be used with special caution:</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Calcium antagonists of the dihydropyridine type</em> such as nifedipine: Concomitant use may increase the risk of hypotension, and an increase in the risk of a further deterioration of the ventricular pump function in patients with heart failure cannot be excluded.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Class I antiarrhythmic drugs</em> (e.g. disopyramide, quinidine, lidocaine, phenytoin, flecainide, propafenone): Effect on atrio-ventricular conduction time and negative inotropic effect may be potentiated.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Class III antiarrhythmic drugs</em> (e.g. amiodarone): Effect on atrio-ventricular conduction time may be potentiated.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Parasympathomimetic dru</em>gs: Concomitant use may increase atrio-ventricular conduction time and thus the risk of bradycardia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Topical beta-blocker containing preparations</em> (e.g. eye drops for glaucoma treatment) may add to the systemic effects of bisoprolol.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Insulin and oral antidiabetic drugs</em>: Intensification of blood sugar lowering effect. Blockade of beta-adrenoceptors may mask symptoms of hypoglycaemia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Anaesthetic agents</em>: Attenuation of the reflex tachycardia and increase of the risk of hypotension (for further information on general anaesthesia see section 4.4).</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Digitalis glycosides</em>: Reduction of heart rate, increase of atrio-ventricular conduction time.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Non-steroidal anti-inflammatory drugs (NSAIDs):</em> NSAIDs may reduce the hypotensive effect of bisoprolol.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Beta-sympathomimetic agents</em> (e.g. isoprenaline, dobutamine): Combination with bisoprolol may reduce the effect of both agents.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Sympathomimetics that activate both beta- and alpha-adrenoceptors</em> (e.g. norepinephrine, epinephrine): Combination with bisoprolol may unmask the alpha-adrenoceptor-mediated vasoconstrictor effects of these agents leading to blood pressure increase. Such interactions are considered to be more likely with nonselective beta-blockers.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Concomitant use with antihypertensive agents</em> <em>as well as with other drugs with blood pressure lowering potential</em> (e.g. tricyclic antidepressants, barbiturates, phenothiazines) may increase the risk of hypotension.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Combinations to be considered:</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Mefloquine</em>: increased risk of bradycardia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Monoamine oxidase inhibitors</em> (except MAO-B inhibitors): Enhanced hypotensive effect of the beta-blockers but also risk for hypertensive crisis.</p><p dir="ltr">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Pregnancy</u></p><p dir="ltr">Bisoprolol has pharmacological effects that may cause harmful effects on pregnancy and/or the foetus/new-born. In general, &beta;-adrenoceptor blockers reduce placental perfusion, which has been associated with growth retardation, intrauterine death, spontaneous abortion and early labour. Adverse effects (e.g. hypoglycaemia and bradycardia) may occur in the foetus and new-born infant. If treatment with &beta;-adrenoceptor blockers is necessary, &beta;1-selective adrenoceptor blockers are preferable.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The safety of amlodipine in human pregnancy has not been established.</p><p dir="ltr">In animal studies, reproductive toxicity was observed at high doses (see section 5.3).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Concor AMLO is not recommended during pregnancy unless clearly necessary. If treatment with Concor AMLO is considered necessary, the uteroplacental blood flow and the foetal growth should be closely monitored. In case of harmful effects on pregnancy or the foetus alternative treatment should be considered. The new-born infant must be closely monitored. Symptoms of hypoglycaemia and bradycardia are generally to be expected within the first 3 days.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Breast-feeding</u></p><p dir="ltr">It is not known whether bisoprolol is excreted in human milk. Amlodipine is excreted in human milk. The proportion of the maternal dose received by the infant has been estimated with an interquartile range of 3 &ndash; 7%, with a maximum of 15%. The effect of amlodipine on infants is unknown. Therefore, administration of Concor AMLO is not recommended during breast-feeding.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Fertility</u></p><p dir="ltr">No human data on fertility are known for the combination product. Reversible biochemical changes in spermatozoa have been reported in some patients treated by calcium channel blockers. Clinical data are insufficient regarding the potential effect of amlodipine on fertility. In one rat study, adverse effects were found on male fertility (see section 5.3).</p><p dir="ltr">Bisoprolol had no influence on fertility or on general reproduction performance in animal studies (see section 5.3).</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Amlodipine can have minor or moderate influence on the ability to drive and use machines. If patients taking amlodipine suffer from dizziness, headache, fatigue or nausea the ability to react may be impaired. In a study with coronary heart disease patients, bisoprolol did not impair driving performance. However, depending on the individual patient&#39;s response to treatment an effect on the ability to drive a vehicle or to use machines cannot be excluded.</p><p dir="ltr">This may occur mostly at the beginning of therapy, during changing therapy and during concomitant alcohol intake.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The undesirable effects observed in the course of using active ingredients separately are to be given according to the following frequency grouping:</p><p dir="ltr">&nbsp;</p><p dir="ltr">Very common (&sup3;&nbsp;1/10)</p><p dir="ltr">Common (&sup3;&nbsp;1/100 to &lt;&nbsp;1/10)</p><p dir="ltr">Uncommon (&sup3;&nbsp;1/1,000 to &lt;&nbsp;1/100)</p><p dir="ltr">Rare (&sup3;&nbsp;1/10,000 to &lt;&nbsp;1/1,000)</p><p dir="ltr">Very rare (&lt;&nbsp;1/10,000)</p><p dir="ltr">Frequency not known (cannot be estimated from the available data)</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>In connection with amlodipine</u></p><p dir="ltr">The most commonly reported adverse reactions during treatment are somnolence, dizziness, headache, palpitations, flushing, abdominal pain, nausea, ankle swelling, oedema and fatigue.</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><em>Blood and lymphatic system disorders</em></p><p dir="ltr">Very rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Leukopenia, thrombocytopenia</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Immune system disorders</em></p><p dir="ltr">Very rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Metabolism and nutrition disorders</em></p><p dir="ltr">Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Psychiatric disorders </em></p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depression, mood changes (including anxiety), insomnia</p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Confusion</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Nervous system disorders</em></p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Somnolence, dizziness, headache (especially at the beginning of the treatment)</p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tremor, dysgeusia, syncope, hypaesthesia, paraesthesia,</p><p dir="ltr">Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypertonia, peripheral neuropathy</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Eye disorders</em></p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Visual disturbances (including diplopia)</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Ear and labyrinth disorders</em></p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tinnitus</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Cardiac disorders</em></p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Palpitation</p><p dir="ltr">Uncommon: &nbsp;&nbsp;&nbsp;&nbsp; Arrhythmia (including bradycardia, ventricular tachycardia and atrial fibrillation)</p><p dir="ltr">Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Myocardial infarction</p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr"><em>Vascular disorders</em></p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flushing</p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypotension</p><p dir="ltr">Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vasculitis</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Respiratory, thoracic and mediastinal disorders</em></p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dyspnoea</p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cough, rhinitis</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Gastrointestinal disorders</em></p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abdominal pain, nausea, dyspepsia, altered bowel habits (including diarrhoea and constipation)</p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting, dry mouth</p><p dir="ltr">Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pancreatitis, gastritis, gingival hyperplasia</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Hepatobiliary disorders</em></p><p dir="ltr">Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis, jaundice, hepatic enzyme increased*</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Skin and subcutaneous tissue disorders</em></p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Alopecia, purpura, skin discolouration, hyperhidrosis, pruritus, rash, exanthema,<s> </s>urticaria</p><p dir="ltr">Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Angioedema, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, Quincke oedema, photosensitivity</p><p dir="ltr">Not known:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toxic epidermal necrolysis</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Musculoskeletal and connective tissue disorders</em></p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ankle swelling, muscle cramps</p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Arthralgia, myalgia, back pain</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Renal and urinary disorders</em></p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Micturition disorder, nycturia, increased urinary frequency</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Reproductive system and breast disorders</em></p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erectile dysfunction, gynecomastia</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>General disorders and administration site conditions</em></p><p dir="ltr">Very common:&nbsp; Oedema</p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fatigue, asthenia</p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pain, pain, malaise</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Investigations</em></p><p dir="ltr">Uncommon: &nbsp;&nbsp;&nbsp;&nbsp; Weight increase, weight decrease</p><p dir="ltr">&nbsp;</p><p dir="ltr">*In most cases with cholestasis</p><p dir="ltr">&nbsp;</p><p dir="ltr">Exceptional cases of extrapyramidal syndrome have been reported.</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><u>In connection with bisoprolol</u></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Metabolism and nutrition disorders</em></p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Elevated triglyceride level</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Psychiatric disorders</em></p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depression, sleep disorder</p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nightmare, hallucination</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Nervous system disorders</em></p><p dir="ltr">Common: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness*<strong>*</strong>, headache*<strong>*</strong></p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Syncope</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Eye disorders</em></p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decreased tear secretion (it must be taken into consideration if the patient wears contact lenses)</p><p dir="ltr">Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Conjunctivitis</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Ear and labyrinth disorders</em></p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hearing impairments</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Cardiac disorders</em></p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AV-conduction disorders, deterioration of pre-existing heart failure, bradycardia</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Vascular disorders</em></p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling of coldness and numbness in the extremities</p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypotension</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Respiratory, thoracic and mediastinal disorders</em></p><p dir="ltr">Uncommon: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bbronchospasm in patients with bronchial asthma or a history of obstructive pulmonary disease<s> </s></p><p dir="ltr">Rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic rhinitis</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Gastrointestinal disorders</em></p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gastrointestinal complaints such as nausea, vomiting, diarrhoea, constipation</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Hepatobiliary disorders</em></p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Skin and subcutaneous tissue disorders</em></p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypersensitivity reactions such as pruritus, flush, rash</p><p dir="ltr">Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Alopecia. Beta-blockers can provoke or aggravate psoriasis or may cause psoriasis like skin disorder</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Musculoskeletal and connective tissue disorders</em></p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle weakness and cramps</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Reproductive system and breast disorders</em></p><p dir="ltr">Rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erectile dysfunction</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>General disorders and administration site conditions</em></p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fatigue*<strong><em>*</em></strong></p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asthenia**</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><em>Investigations</em></p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased liver enzymes (ALAT, ASAT)</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong><em>*</em></strong>*These symptoms especially occur at the beginning of the therapy. They are generally mild and often disappear within 1-2 weeks.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">To report any side effect(s):</p><ul dir="ltr"><li><strong><em>Saudi Arabia: </em></strong></li></ul><p dir="ltr">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" dir="ltr"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p><strong>- </strong>The National Pharmacovigilance Centre (NPC)</p><ul><li>Fax: +966-11-205-7662</li><li>Toll free phone: 19999</li><li>E-mail: npc.drug@sfda.gov.sa&nbsp;&nbsp;</li><li>Website: https://ade.sfda.gov.sa/</li></ul><p>&nbsp;</p></td></tr></tbody></table><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp; Other GCC States:</p><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>In connection with amlodipine:</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">In humans experience with intentional overdose is limited.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Symptoms</em></p><p dir="ltr">Available data suggest that gross overdosage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged systemic hypotension up to and including shock with fatal outcome have been reported.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Treatment </em></p><p dir="ltr">Clinically significant hypotension due to amlodipine overdosage calls for active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities and attention to circulating fluid volume and urine output.</p><p dir="ltr">A vasoconstrictor may be helpful in restoring vascular tone and blood pressure, provided that there is no contraindication to its use. Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade.</p><p dir="ltr">Gastric lavage may be worthwhile in some cases. In healthy volunteers the use of charcoal up to 2 hours after administration of amlodipine 10 mg has been shown to reduce the absorption rate of amlodipine.</p><p dir="ltr">Since amlodipine is highly protein-bound, dialysis is not likely to be of benefit.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>In connection with bisoprolol:</u></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Symptoms</em></p><p dir="ltr">The most common signs expected with overdosage of a &beta;-blocker are bradycardia, hypotension, bronchospasm, acute cardiac insufficiency and hypoglycaemia. To date a few cases of overdose with bisoprolol in hypertensive and/or ischemic heart disease patients have been reported: Bradycardia and/or hypotension were noted. All patients recovered. There is a wide interindividual variation in sensitivity and in reactions to one single high dose of bisoprolol, patients with heart disease are obviously more sensitive to the effects of bisoprolol.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Treatment</em></p><p dir="ltr">In general, if overdose occurs, bisoprolol treatment should be stopped and supportive and symptomatic treatment should be provided. Limited data suggest that bisoprolol is hardly dialysable.</p><p dir="ltr">Based on the expected pharmacological actions and recommendations for other &beta;-blockers, the following general measures should be considered when clinically warranted.</p><p dir="ltr"><em>Bradycardia:</em> Administer intravenous atropine. If the response is inadequate, isoprenaline or another agent with positive chronotropic properties may be given cautiously. Under some circumstances, transvenous pacemaker insertion may be necessary.</p><p dir="ltr"><em>Hypotension:</em> Intravenous fluids and vasopressors should be administered. Intravenous glucagon may be useful.</p><p dir="ltr"><em>AV block (second or third degree):</em> Patients should be carefully monitored and treated with isoprenaline infusion or cardiac pacemaker insertion.</p><p dir="ltr"><em>Acute worsening of heart failure:</em> I.v. diuretics, positive inotropic agents, vasodilating agents should be administered.</p><p dir="ltr"><em>Bronchospasm:</em> Bronchodilator therapy such as isoprenaline, &beta;<sub>2</sub>-sympathomimetic drugs and/or aminophylline should be administered.</p><p dir="ltr"><em>Hypoglycaemia:</em> I.v. glucose should be administered.</p><p dir="ltr">&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Pharmacotherapeutic group: Beta blocking agents, selective, and other antihypertensives.</p><p dir="ltr">ATC code: C07FB07</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Mechanism of action of amlodipine:</u></p><p dir="ltr">Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.</p><p dir="ltr">The mechanism of the antihypertensive action of amlodipine is due to a direct relaxant effect on vascular smooth muscle. The precise mechanism by which amlodipine relieves angina has not been fully determined, but amlodipine reduces total ischaemic burden by the following two actions:</p><p dir="ltr">1) Amlodipine dilates peripheral arterioles and thus, reduces the total peripheral resistance (afterload) against which the heart works. Since the heart rate remains stable, this unloading of the heart reduces myocardial energy consumption and oxygen requirements.</p><p dir="ltr">2) The mechanism of action of amlodipine also probably involves dilatation of the main coronary arteries and coronary arterioles, both in normal and ischaemic regions. This dilatation increases myocardial oxygen delivery in patients with coronary artery spasm (Prinzmetal&#39;s or variant angina).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Pharmacodynamic effects:</u></p><p dir="ltr">In patients with hypertension, once daily dosing provides clinically significant reductions of blood pressure in both the supine and standing positions throughout the 24-hour interval. Due to the slow onset of action, acute hypotension is not a feature of amlodipine administration.</p><p dir="ltr">In patients with angina, once daily administration of amlodipine increases total exercise time, time to angina onset, and time to 1 mm ST segment depression, and decreases both angina attack frequency and glyceryl trinitrate tablet consumption.</p><p dir="ltr">Amlodipine has not been associated with any adverse metabolic effects or changes in plasma lipids and is suitable for use in patients with asthma, diabetes, and gout.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Mechanism of action of bisoprolol:</u></p><p dir="ltr">Bisoprolol is a potent, highly &beta;<sub>1</sub>-selective adrenoreceptor-blocking agent devoid of intrinsic sympathomimetic activity (ISA) and without relevant membrane stabilising activity.</p><p dir="ltr">It only shows low affinity to the &beta;<sub>2</sub>-receptor of the smooth muscles of bronchi and vessels as well as to the &beta;<sub>2</sub>-receptors concerned with metabolic regulation. Therefore, bisoprolol is generally not to be expected to influence the airway resistance and &beta;<sub>2</sub>-mediated metabolic effects. Its &beta;<sub>1</sub>-selectivity extends beyond the therapeutic dose range. Bisoprolol has no explicit negative inotropic effect.</p><p dir="ltr">Bisoprolol has its maximal effect 3-4 hours after oral administration.</p><p dir="ltr">The plasma elimination half-life (10-12 hours) provides 24 hours efficacy following a once daily dosage.</p><p dir="ltr">It usually exerts its maximal antihypertensive effect after 2 weeks.</p><p dir="ltr">In acute administration in patients with coronary heart disease without chronic heart failure bisoprolol reduces the heart rate and stroke volume and thus the cardiac output and oxygen consumption. In chronic administration the initially elevated peripheral resistance decreases.</p><p dir="ltr">Antihypertensive effect of beta-blockers is among others due to decrease of renin activity.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Pharmacodynamic effects of the combination product</u></p><p dir="ltr">This combination allows to increase the antihypertensive and anti-anginal efficacy by complementary mechanism of actions of the two active compounds: vasoselective effect of the calcium channel blocker amlodipine (decrease of peripheral resistance) and cardio selective beta-blocker bisoprolol (decrease of cardiac output).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Amlodipine:</u></p><p dir="ltr"><em><u>Absorption, </u></em><em><u>distribution, plasma protein binding</u></em><em><u>:</u></em></p><p dir="ltr">After oral administration of therapeutic doses, amlodipine is well absorbed with peak blood levels between 6-12 hours post dose. Absolute bioavailability has been estimated to be between 64 and 80%. The volume of distribution is approximately 21 l/kg. In vitro studies have shown that approximately 97.5% of circulating amlodipine is bound to plasma proteins.</p><p dir="ltr">The bioavailability of amlodipine is not affected by food intake.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em><u>Biotransformation</u></em><em><u>/elimination:</u></em></p><p dir="ltr">The terminal plasma elimination half-life is about 35-50 hours and is consistent with once daily dosing. Amlodipine is extensively metabolised by the liver to inactive metabolites with 10% of the parent compound and 60% of metabolites excreted in the urine.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Hepatic impairment:</em></p><p dir="ltr">Very limited clinical data are available regarding amlodipine administration in patients with hepatic impairment. Patients with hepatic insufficiency have decreased clearance of amlodipine resulting in a longer half-life and an increase in AUC of approximately 40-60%.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Elderly population:</em></p><p dir="ltr">The time to reach peak plasma concentrations of amlodipine is similar in elderly and younger subjects. Amlodipine clearance tends to be decreased with resulting increases in AUC and elimination half-life in elderly patients. Increases in AUC and elimination half-life in patients with congestive heart failure were as expected for the patient age group studied.</p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr"><u>Bisoprolol:</u></p><p dir="ltr"><em>Absorption:</em></p><p dir="ltr">Bisoprolol is absorbed almost completely (&gt; 90%) from the gastrointestinal tract. Due to the very small first pass effect (approx. 10%), its absolute bioavailability is approximately 90% after oral administration.</p><p dir="ltr"><em>Distribution:</em></p><p dir="ltr">Its distribution volume is 3.5 l/kg. The plasma protein binding of bisoprolol is about 30%.</p><p dir="ltr"><em>Metabolism and elimination:</em></p><p dir="ltr">Bisoprolol is excreted from the body by two routes. 50% is metabolised by the liver to inactive metabolites, which are then excreted by the kidneys. The remaining 50% is excreted by the kidneys in unmetabolized form. Since the elimination takes place in the kidneys and the liver to the same extent a dosage adjustment is not required for patients with mild to moderate liver function impairment or renal insufficiency. Total clearance is approximately 15 l/h.</p><p dir="ltr">The elimination half-life in plasma is 10-12 hours.</p><p dir="ltr">The kinetics of bisoprolol are linear and independent of age.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Combination product</u></p><p dir="ltr">A pharmacokinetic interaction study demonstrated no interaction between the two compounds.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>In connection with amlodipine:</u></p><p dir="ltr"><em><u>Reproductive toxicology</u></em></p><p dir="ltr">Reproductive studies in rats and mice have shown delayed date of delivery, prolonged duration of labour and decreased pup survival at dosages approximately 50 times greater than the maximum recommended dosage for humans based on mg/kg.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em><u>Impairment of fertility</u></em></p><p dir="ltr">There was no effect on the fertility of rats treated with amlodipine (males for 64 days and females 14 days prior to mating) at doses up to 10 mg/kg/day (8 times* the maximum recommended human dose of 10 mg on a mg/m<sup>2</sup>&nbsp;basis). In another rat study in which male rats were treated with amlodipine besilate for 30 days at a dose comparable with the human dose based on mg/kg, decreased plasma follicle-stimulating hormone and testosterone were found as well as decreases in sperm density and in the number of mature spermatids and Sertoli cells.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em><u>Carcinogenesis, </u></em><em><u>mutagenesis</u></em><em>:</em></p><p dir="ltr">Rats and mice treated with amlodipine in the diet for two years, at concentrations calculated to provide daily dosage levels of 0.5, 1.25, and 2.5 mg/kg/day, showed no evidence of a carcinogenicity. The highest dose (for mice, similar to, and for rats twice* the maximum recommended clinical dose of 10 mg on a mg/m<sup>2</sup>&nbsp;basis) was close to the maximum tolerated dose for mice but not for rats.</p><p dir="ltr">Mutagenicity studies revealed no drug related effects at either the gene or chromosome levels.</p><p dir="ltr">*Based on patient weight of 50 kg</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>In connection with bisoprolol:</u></p><p dir="ltr">Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.</p><p dir="ltr">During reproduction toxicology tests bisoprolol had no influence on fertility or general reproduction ability.</p><p dir="ltr">Like other beta-blockers, bisoprolol caused maternal (decreased food intake and decreased body weight increase) and embryo/fetal toxicity (increased incidence of resorptions, reduced birth weight of the offspring, retarded physical development) but was not teratogenic.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">&nbsp;</p><p dir="ltr">For Concor AMLO 5/5 mg:</p><p dir="ltr">&nbsp;</p><p dir="ltr">Silica, colloidal anhydrous 130.55 mg</p><p dir="ltr">Magnesium stearate 1.5 mg</p><p dir="ltr">Sodium starch glycolate (type A) 5.00&nbsp;&nbsp;&nbsp; mg</p><p dir="ltr">Cellulose, microcrystalline 1.00 mg</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">For Concor AMLO 5/10 mg:</p><p dir="ltr">&nbsp;</p><p dir="ltr">Silica, colloidal anhydrous 261.10 mg</p><p dir="ltr">Magnesium stearate 3.00&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mg</p><p dir="ltr">Sodium starch glycolate (type A) 10.00 mg</p><p dir="ltr">Cellulose, microcrystalline 2.00 mg</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">This medicinal product does not require any special temperature storage conditions. Store in the original container in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">28, 30, 56, or 90 tablets in OPA/Al/PVC//Al blister and carton box.</p><p dir="ltr">Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
Merck KFT
Oktober huzonharmadika utca 6-10
H-1117, Budapest
Hungary 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                25 Feb 2021 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>